Insurance Coverage for Gender-Affirming Voice and Communication Services: An In-Depth Analysis in a Midwestern U.S. State.
Autor: | Dubey, Ishita, Stryker, Shanna D., Madzia, Jules L., Pickle, Sarah, Dion, Gregory R., McKenna, Victoria S. |
---|---|
Předmět: |
VOICE disorder treatment
CROSS-sectional method GENDER-nonconforming people HEALTH insurance reimbursement INSURANCE RESEARCH funding GENDER affirming care HEALTH policy SOCIOECONOMIC factors QUESTIONNAIRES DESCRIPTIVE statistics ELECTRONIC health records ATTITUDES of medical personnel MEDICAL needs assessment DISCRIMINATION (Sociology) MEDICAL care costs PATIENTS' attitudes INSURANCE companies |
Zdroj: | Perspectives of the ASHA Special Interest Groups; Jun2024, Vol. 9 Issue 3, p490-511, 22p |
Abstrakt: | Purpose: The aim of this study was to explore the gap between the need for gender-affirming voice and communication services (GAVCS) and insurance coverage within one state. Method: An electronic, cross-sectional survey of transgender/gender-diverse (TGD) adults assessed the incidence of insurance and cost barriers to GAVCS. Then, policies from 22 major insurers were reviewed using a web-based search and telephone inquiries. Finally, a tool was developed for clinicians to share available coverage for GAVCS by insurer. Results: Over half (53%) of 115 respondents reported vocal incongruence, but only 19.1% had pursued GAVCS. Of those who had not, 57% reported cost and/or insurance coverage were barriers (most of whom were commercially insured). Less than half of major Ohio insurance plans mentioned GAVCS coverage, and of those who did, less than half would consider covering it on a caseby- case basis. Creation of a tool that explained coverage across insurance companies was helpful, but challenging and labor-intensive. Conclusions: TGD individuals often experience a mismatch between their gender identity and societal perceptions of their voice, which can worsen dysphoria and compromise safety. GAVCS align voice with gender identity but are inconsistently covered by health insurance and can be costly, particularly for individuals who face socioeconomic marginalization. Inconsistent transparency in communicating coverage criteria further exacerbates access to GAVCS. Poor insurance coverage of GAVCS is an important barrier to accessing this evidence-based care, and more transparency and consistency in coverage is critical. [ABSTRACT FROM AUTHOR] |
Databáze: | Complementary Index |
Externí odkaz: |